[
  {
    "diagnosis_characteristics": [
      {
        "primary_cancer_condition": "Prostate Cancer",
        "diagnosis_date": null,
        "histology": [
          "Invasive ductal carcinoma"
        ],
        "stage": {
          "T": null,
          "N": null,
          "M": null,
          "group_stage": null
        }
      }
    ],
    "cancer_related_medications": [
      {
        "medication_name": "Prostate-Specific Antigen (PSA)",
        "start_date": "03-01-2025",
        "end_date": null,
        "intent": "Assess for possible prostate abnormalities"
      }
    ]
  },
  {
    "diagnosis_characteristics": [
      {
        "primary_cancer_condition": "Prostate Cancer",
        "diagnosis_date": null,
        "histology": [
          "Benign prostatic hyperplasia with focal nodular changes",
          "Low-grade prostatitis",
          "Prostate Cancer"
        ],
        "stage": {
          "T": null,
          "N": null,
          "M": null,
          "group_stage": null
        }
      }
    ],
    "cancer_related_medications": [
      {
        "medication_name": null,
        "start_date": null,
        "end_date": null,
        "intent": null
      }
    ]
  },
  {
    "diagnosis_characteristics": [
      {
        "primary_cancer_condition": "Prostate Cancer",
        "diagnosis_date": null,
        "histology": null,
        "stage": {
          "T": null,
          "N": null,
          "M": null,
          "group_stage": null
        }
      }
    ],
    "cancer_related_medications": [
      {
        "medication_name": "Fluoroquinolone",
        "start_date": "03-24-2025",
        "end_date": "04-24-2025",
        "intent": "Prophylactic antibiotics to minimize infectious complications"
      }
    ]
  },
  {
    "diagnosis_characteristics": [
      {
        "primary_cancer_condition": "Prostate Cancer",
        "diagnosis_date": null,
        "histology": [
          "Adenocarcinoma"
        ],
        "stage": {
          "T": "Not specified",
          "N": "Not specified",
          "M": "Not specified",
          "group_stage": "Not specified"
        }
      }
    ],
    "cancer_related_medications": []
  },
  {
    "diagnosis_characteristics": [
      {
        "primary_cancer_condition": "Prostate Cancer",
        "diagnosis_date": null,
        "histology": [
          "Adenocarcinoma"
        ],
        "stage": {
          "T": null,
          "N": null,
          "M": null,
          "group_stage": null
        }
      }
    ],
    "cancer_related_medications": [
      {
        "medication_name": null,
        "start_date": null,
        "end_date": null,
        "intent": null
      }
    ]
  },
  {
    "diagnosis_characteristics": [
      {
        "primary_cancer_condition": "Prostate Cancer",
        "diagnosis_date": null,
        "histology": [
          "Gleason 7 (3+4) prostate adenocarcinoma"
        ],
        "stage": {
          "T": "T2",
          "N": "N0",
          "M": "M0",
          "group_stage": "Stage T2 N0 M0"
        }
      }
    ],
    "cancer_related_medications": []
  },
  {
    "diagnosis_characteristics": [
      {
        "primary_cancer_condition": "Prostate Cancer",
        "diagnosis_date": "Not specified",
        "histology": [
          "Adenocarcinoma"
        ],
        "stage": {
          "T": "T2",
          "N": "N0",
          "M": "M0",
          "group_stage": "Stage T2N0M0"
        }
      }
    ],
    "cancer_related_medications": [
      {
        "medication_name": "Androgen Deprivation Therapy (ADT)",
        "start_date": "Not specified",
        "end_date": "4-6 months",
        "intent": "Short-term androgen deprivation (4\u20136 months) is sometimes added for intermediate-risk disease to enhance the effectiveness of radiation, though it\u2019s not universally required."
      }
    ]
  },
  {
    "diagnosis_characteristics": [
      {
        "primary_cancer_condition": "Prostate Cancer",
        "diagnosis_date": null,
        "histology": null,
        "stage": null
      }
    ],
    "cancer_related_medications": null
  },
  {
    "diagnosis_characteristics": [
      {
        "primary_cancer_condition": "Prostate Cancer",
        "diagnosis_date": "05-15-2025",
        "histology": "Localized prostate cancer, Gleason 3+4=7",
        "stage": {
          "T": "T2",
          "N": "N0",
          "M": "M0",
          "group_stage": "Not specified"
        }
      }
    ],
    "cancer_related_medications": [
      {
        "medication_name": null,
        "start_date": null,
        "end_date": null,
        "intent": null
      }
    ]
  },
  {
    "diagnosis_characteristics": null,
    "cancer_related_medications": null
  },
  {
    "diagnosis_characteristics": [
      {
        "primary_cancer_condition": "Prostate Cancer",
        "diagnosis_date": "05-22-2025",
        "histology": [
          "Adenocarcinoma"
        ],
        "stage": {
          "T": "T2",
          "N": "N0",
          "M": "M0",
          "group_stage": "Stage I"
        }
      }
    ],
    "cancer_related_medications": []
  },
  {
    "diagnosis_characteristics": [
      {
        "primary_cancer_condition": "Prostate Cancer",
        "diagnosis_date": "04-14-2023",
        "histology": [
          "pT2 N0"
        ],
        "stage": {
          "T": "2",
          "N": "0",
          "M": "0",
          "group_stage": "Stage I"
        }
      }
    ],
    "cancer_related_medications": [
      {
        "medication_name": "PDE5 inhibitors",
        "start_date": "06-12-2025",
        "end_date": null,
        "intent": "Rehabilitation for erectile function"
      }
    ]
  },
  {
    "diagnosis_characteristics": [
      {
        "primary_cancer_condition": "Prostate Cancer",
        "diagnosis_date": null,
        "histology": null,
        "stage": null
      }
    ],
    "cancer_related_medications": [
      {
        "medication_name": "PDE5 inhibitor",
        "start_date": "06-15-2025",
        "end_date": null,
        "intent": "penile rehabilitation"
      }
    ]
  },
  {
    "diagnosis_characteristics": [
      {
        "primary_cancer_condition": "Prostate Cancer",
        "diagnosis_date": null,
        "histology": [
          "Gleason 7"
        ],
        "stage": null
      }
    ],
    "cancer_related_medications": [
      {
        "medication_name": "PDE5 inhibitors",
        "start_date": null,
        "end_date": null,
        "intent": "To aid in better sexual function"
      }
    ]
  },
  {
    "diagnosis_characteristics": [
      {
        "primary_cancer_condition": "Prostate Cancer",
        "diagnosis_date": null,
        "histology": null,
        "stage": null
      }
    ],
    "cancer_related_medications": [
      {
        "medication_name": "PDE5 inhibitor",
        "start_date": null,
        "end_date": null,
        "intent": "To maximize continence and erectile recovery"
      }
    ]
  }
]